Fc Mutagenesis

Fc Mutagenesis is a targeted engineering methodology involving the systematic alteration of amino acid residues within the crystallizable fragment (Fc) region of an antibody to modulate its effector functions, stability, and pharmacokinetic properties while preserving structural integrity.

24

Publications

2.2K

Citations

186

Authors

55

Institutions

Publications per year

2017–2026

7

Authors

186

  1. ES
    E. Sally Ward

    The University of Texas Southwestern Medical Center, United States

    3 publications · 681 citations

    3

    h-index

  2. HW
    Herren Wu

    AstraZeneca (Germany), Germany

    3 publications · 651 citations

    3

    h-index

  3. VO
    Vaheh Oganesyan

    AstraZeneca (Germany), Germany

    2 publications · 284 citations

    2

    h-index

  4. PM
    P. Mark Hogarth

    The University of Melbourne, Australia

    2 publications · 67 citations

    2

    h-index

  5. VG
    Victor Gheţie

    The University of Texas Southwestern Medical Center, United States

    2 publications · 314 citations

    2

    h-index

1–5 of 186

Venues

  1. The Journal of Immunology

    JI · 4 publications · 670 citations

    4

    h-index

  2. Protein Engineering Design and Selection

    PEDS · 3 publications · 580 citations

    3

    h-index

  3. mAbs

    3 publications · 81 citations

    3

    h-index

  4. Frontiers in Immunology

    1 publications · 15 citations

    1

    h-index

  5. 1

    h-index

1–5